Navigation Links
Combination of Herceptin and Hormonal therapy to Fight Cancer

Breast cancer will soon be fought with a combined treatment of hormonal therapy and the drug, Herceptin that has been shown to slow // the progress of breast cancer by over half, according to a recent report.

Following these findings a call has been made for the treatment to be made available for even more women with breast cancer.

The study showed that the addition of Herceptin to hormonal therapy kept a control over the cancer for a significantly longer period than hormonal therapy alone in patients whose advanced breast cancer was hormone receptor-positive, as well as HER2-positive.

It was found that the median progression-free survival doubled at 4.8 months for patients who received the combination therapy on comparison with the 2.4 months for patients who received hormonal therapy.

In addition it was found that another 15 per cent of high-risk patients treated with the combination therapy showed no progress of disease for at least two years. The results from the study have been presented at a meeting of the European Society for Medical Oncology.

According to experts the study demonstrated that Herceptin should be considered the essential component in the treatment of all HER2-positive breast cancers.

It has been estimated that HER2-positive breast cancer affects up to 30 per cent of women with the complaint. This is an aggressive form of the disease where special and immediate attention is required because the tumors are fast-growing and there is a higher likelihood of relapse.

So far over 3000 patients with HER2-positive breast cancer in both early and metastatic, stages have been treated with Herceptin in Australia.

The Pharmaceutical Benefits Scheme has made the drug available in it.

Page: 1

Related medicine news :

1. Consensus on "Combination Therapy" for Breast Cancer
2. Drug Combinations May Boost Stroke Risk
3. Combination therapy to treat breast cancer
4. Combination regime may work against prostate cancer
5. Smoking and Breast Cancer - A Deadly Combination
6. New Drug Combination Found To Improve Memory in Alzheimer’s Patient
7. A Combination Of Drugs Effective In The Treatment Of Hormone-Refractory Prostate Cancer
8. Combination Therapy Effective In Improving Lung Cancer Survival
9. Combination Therapy Found To Improves Stroke Recovery
10. Combination Therapy Found To Be More Effective In Treating Brain Cancer
11. Combination of Clopidogrel-aspirin is better for preventing stroke than only aspirin
Post Your Comments:

(Date:11/30/2015)... Fla. (PRWEB) , ... November 30, 2015 , ... ... opened the driverless vehicle experience this summer, ushering in a new era of ... percent driverless and electric shuttle, will continue to offer guests an up-close look ...
(Date:11/30/2015)... ... 30, 2015 , ... The presidential race normally deals with political issues of ... a national news story when Donald Trump makes disparaging remarks about Hillary Clinton’s hairstyle? ... than anyone wants to admit when it comes to how people are viewed by ...
(Date:11/30/2015)... , ... November 30, 2015 , ... ... continuing education course in Dallas, TX, on January 29 and 30, 2016. The ... improve the functions of their practices, to learn how to better succeed in ...
(Date:11/30/2015)... ... November 30, 2015 , ... ... component of bacteria could be effective in fighting methicillin-resistant Staphylococcus aureus (MRSA), one ... , Their study showed that small molecule analogs that target the functions of ...
(Date:11/30/2015)... ... 30, 2015 , ... Dr. Seth D. Margulies specializes in orthodontics and is ... Margulies to experience the best available orthodontic experience in the area. Dr. Margulies ... , Orthodontics is the branch of dentistry that specializes in the diagnosis, prevention, and ...
Breaking Medicine News(10 mins):
(Date:11/30/2015)... -- IBA Molecular North America, Inc. (IBAMNA), a U.S. leader ... as of January 1, 2016, it will do business ... rebrand the company reflects a refined vision for the ... relationship with Zevacor Molecular.  Both IBAMNA and Zevacor Molecular ... Peter Burke , Vice President Sales and ...
(Date:11/30/2015)... -- North America was valued at ... a CAGR of 7.6% from 2015 to 2020. --> ... in 2014, and is expected to grow at a CAGR of ... new Market Research Report "North America Cardiac Output Monitoring Devices Market ... care, others) - Analysis And Forecast To 2020", the cardiac output ...
(Date:11/30/2015)... , Nov. 30, 2015  Kevin Smith ... Sensium Healthcare, a global pioneer in wireless monitoring ... Boston, MA , Mr. Smith will ... Sensium,s global commercial strategy.  He will also directly ... to build clinical evidence for SensiumVitals, the first ...
Breaking Medicine Technology: